Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Trumab 150mg Injection

Prescription Icon
Prescription Required

Marketer

Glenmark Pharmaceuticals Ltd

Salt Composition

Trastuzumab (150mg)

Overview Trumab 150mg Injection

Herceptin-equivalent injection (150mg) treats breast and gastric cancers by targeting and eliminating HER2-positive cells. Administered intravenously by a healthcare professional, dosage and frequency are determined individually by your physician, based on your condition and may vary. Strict adherence to the prescribed regimen is crucial; incorrect usage or overdose can lead to severe complications. Therapeutic effects might not be immediately apparent, potentially taking weeks or months; discontinuation should only occur under medical supervision. Common side effects include nausea, headache, skin rash, sleep disturbances, and increased infection risk. This medication can decrease blood cell counts, raising infection vulnerability, necessitating regular blood tests to monitor blood cell levels, cardiac function, liver health, and uric acid. Report shortness of breath, cough, chills, or limb swelling immediately. Inform your doctor of all other medications you are taking, as interactions are possible. Pregnancy and breastfeeding are contraindicated; effective contraception is essential for both partners throughout treatment.

Primary Ingredients of Trumab 150mg Injection

No information provided. Please provide the text you wish me to rephrase.

Uses of Trumab 150mg Injection

Cancers affecting the breast and stomach

Major Benefits of Trumab 150mg Injection:

Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Trumab 150mg Injection:

  • Anemia (low number of red blood cells)
  • Chills
  • Common cold
  • Cough
  • Decreased blood cells (red cells, white cells, and platelets)
  • Diarrhea
  • Fatigue
  • Fever
  • Headache
  • Heart failure
  • Infection
  • Insomnia (difficulty in sleeping)
  • Mucosal inflammation
  • Nausea
  • Rash
  • Stomatitis (Inflammation of the mouth)
  • Taste change
  • Upper respiratory tract infection
  • Weight loss

How to use Trumab 150mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Trumab 150mg Injection works:

The injectable medication Trumab (150mg) is a genetically engineered IgG1 antibody. Its mechanism involves targeting and neutralizing HER2 receptors—proteins that drive excessive growth in breast and gastric cancers. This action directly eliminates cancer cells and concurrently blocks multiple downstream signaling pathways implicated in cancer development.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concomitant use of Trumab 150mg Injection and alcohol can lead to significant somnolence.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering 150mg of Trumab via injection is contraindicated during pregnancy due to confirmed risks to fetal development. In exceptional, life-threatening circumstances, a physician might consider its use if the potential benefits outweigh the hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The administration of Trumab 150mg Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Trumab 150mg Injection on driving ability is unknown. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

The use of 150mg Trumab Injection in patients with kidney impairment appears to pose minimal risk. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is recommended.

LiverLiverCONSULT YOUR DOCTOR

Data regarding Trumab 150mg Injection use in individuals with hepatic impairment is scarce. Physician consultation is recommended.

What if you forget to take Trumab 150mg Injection :

Should you forget a scheduled Trumab 150mg Injection, seek your physician's advice.

Facts to Know About Trumab 150mg Injection

LabelValue
Chemical Category Monoclonal antibody
Developing Habits No.
Type of Therapy Cancer Medications
Actions Monoclonal antibody HER2/neu (ErbB2) inhibitor

FAQs on Trumab 150mg Injection

Trumab 150mg Injection may cause side effects including sore throat, fever, chills, fatigue, pale skin, nosebleeds, and unusual bleeding or bruising. Other possible side effects are stomach pain, seizures, hallucinations, muscle cramps and spasms, nausea or vomiting, appetite loss, rapid heartbeat, urine discoloration, decreased or painful urination, difficulty urinating, and signs of infection. Contact your doctor immediately if you experience any of these symptoms.
Effective contraception is recommended for women of childbearing age throughout Trumab 150mg Injection therapy and for seven months afterward. Pregnancy planning may resume seven months post-treatment.
Treatment with Trumab 150mg Injection for early breast cancer should last one year, or until disease recurrence, whichever comes first. Treatment should not exceed one year.
Trumab 150mg Injection does not require fasting beforehand. Administration must be supervised by a physician experienced in administering cancer chemotherapy, and should only be performed by a qualified healthcare professional.
Trumab 150mg Injection is available in two formulations: intravenous (IV) infusion and subcutaneous (SC) injection. Always verify the correct formulation is administered as prescribed, as the IV formulation is exclusively for intravenous use. Your doctor can change your treatment between the IV and SC formulations if deemed suitable.
Trumab 150mg Injection, a monoclonal antibody, targets the HER2 protein found on some cancer cells. Because it works by binding to HER2 to inhibit cancer growth, it's only effective in patients with HER2-positive cancer; it's not indicated for use in HER2-negative patients.
Using Trumab 150mg Injection with anthracycline-based cancer drugs (such as doxorubicin) can harm your heart. Therefore, your doctor must assess your heart health before and during treatment.
Cardiac evaluations are required at treatment initiation, every three months during treatment, and every six months post-treatment for 24 months following the final Trumab 150mg Injection dose. Patients with pre-existing cardiac conditions require evaluation every 12 weeks.
Trumab 150mg Injection
7,830